Trypsin-Catalyzed Amidation of C-Terminal Peptides

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing C-terminally amidated di- or polybasic peptides, such as those with biological activity like GLP-1, face challenges in scalability, cost, and yield due to limitations in chemical synthesis and biotechnological processes, including low yields, costly enzyme preparation, and inefficient amidation processes.

Innovation Solution

A trypsin-catalyzed semisynthesis process that involves reacting a peptide with a C-terminal basic amino acid with a compound containing amidated basic amino acids, eliminating the need for protective groups and enabling high-yield ligation of amidated basic amino acids to peptides, thereby simplifying the production of C-terminally amidated peptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If chemical synthesis is used to prepare C-terminally amidated peptides, then the peptides can be produced with high purity, but the process becomes too complicated and yields are restricted when preparing large quantities

Engineering Contradiction:
Improvepeptide purityVSAvoidproduction quantity
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The peptide synthesis process is divided into two separate steps: first, the peptide backbone is synthesized using standard chemical methods to achieve high purity; second, the C-terminal amidation is performed enzymatically using peptidylglycine alpha-amidating enzyme (PAM). This segmentation allows each step to be optimized independently, maintaining purity while enabling scalable production.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces peptidylglycine alpha-amidating enzyme (PAM) as an intermediary catalyst to perform the C-terminal amidation step. This enzymatic intermediary replaces complex multi-step chemical amidation procedures, simplifying the process and improving scalability while maintaining product purity and yield.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If peptidylglycine alpha-amidating enzyme (PAM) is used for C-terminal amidation, then amidation can be achieved, but the enzyme preparation is costly compared to other industrial enzymes

Engineering Contradiction:
Improveamidation specificityVSAvoidenzyme preparation cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs a self-service approach by using PAM enzyme that specifically recognizes and acts on C-terminal glycine residues. The enzyme performs the amidation reaction automatically at the C-terminus without requiring additional substrates or complex conditioning, simplifying the process and reducing operational costs while maintaining high specificity.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent optimizes reaction parameters including pH (typically 7-9), temperature (20-40°C), and substrate concentration to maximize PAM enzyme activity. By carefully controlling these parameters, the process achieves high amidation efficiency while minimizing enzyme consumption and preparation costs.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If coexpression of PAM enzyme with precursor protein is used, then amidation can occur in the host cell, but the yields are low and purification becomes more costly and complex

Engineering Contradiction:
Improveamidation convenienceVSAvoidpeptide yield
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent extracts the amidation function from the host cell system and performs it in a separate enzymatic step using purified PAM enzyme. This extraction allows the host cell to be optimized for peptide production without the complications of coexpressing multiple genes, thereby improving yield while maintaining operational convenience through the specific enzymatic action of PAM.

Inventive Principle:
Principle #2Taking out (Extraction)

4Device complexity

If traditional chemical amidation methods are used without enzymatic catalysis, then the process can be simpler, but yields are restricted and by-product formation occurs

Engineering Contradiction:
Improveprocess simplicityVSAvoidreaction yield
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent introduces PAM enzyme as an intermediary that mediates the C-terminal amidation reaction. This enzymatic intermediary provides high specificity and efficiency, preventing by-product formation and improving yield while maintaining process simplicity. The enzyme acts as a catalyst that facilitates the reaction without requiring harsh conditions or complex reagent systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process allows for the efficient production of C-terminally amidated peptides with high yields, reducing production costs and avoiding the complexities of traditional methods, making large-scale production more feasible and cost-effective.

Implementation Method 1

reacting a peptide with a C-terminal basic amino acid with a compound containing amidated basic amino acids, eliminating the need for protective groups and enabling high-yield ligation of amidated basic amino acids to peptides

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

A trypsin-catalyzed semisynthesis process that involves reacting a peptide with a C-terminal basic amino acid

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS8765910B2Method for amidating polypeptides with basic amino acid C-terminals by means of specific endoproteases
Publication Date: 2014.07.01 SANOFI AVENTIS DEUT GMBH

AI summary

The invention relates to a method for producing C-terminal amidated dibasic or polybasic peptides, consisting in reacting two peptides in the presence of trypsin biologically active enzymes and, if necessary, in purifying the thus obtainable compounds of formula (I) by means of protein chemistry.